Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Freeman

Showing results (841-850 of 857) with videos related to

Pageof 86
Sort By:
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Cell Chemical Biology|March 19, 2019
Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven TranscriptionNicholas B Struntz, Andrew Chen, Anja Deutzmann, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.
Nature Communications|September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Gates Open Research|January 16, 2023
Limiting adverse birth outcomes in resource-limited settings (LABOR): protocol of a prospective intrapartum cohort studyAmanda Adu-Amankwah, Mrutunjaya B Bellad, Aimee M Benson, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Jvs-Vascular Insights|January 13, 2025
Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategyMatthew P Goldman, Dipal M Patel, Kevin Z Chang, et al.
Cell Chemical Biology|October 21, 2020
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.
Pageof 86

Showing results (841-850 of 857) with videos related to

Sort By:
Pageof 86
Nature Communications|November 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastomaMin Pan, William C Wright, Richard H Chapple, et al.
Cell Chemical Biology|March 19, 2019
Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven TranscriptionNicholas B Struntz, Andrew Chen, Anja Deutzmann, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Human Genetics|January 25, 2012
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang, Hemang Parikh, Jinping Jia, et al.
Nature Communications|September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Gates Open Research|January 16, 2023
Limiting adverse birth outcomes in resource-limited settings (LABOR): protocol of a prospective intrapartum cohort studyAmanda Adu-Amankwah, Mrutunjaya B Bellad, Aimee M Benson, et al.
Nature Communications|July 3, 2021
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade gliomaChen He, Ke Xu, Xiaoyan Zhu, et al.
Jvs-Vascular Insights|January 13, 2025
Challenges and potential solutions to enrollment in a clinical trial of arteriovenous fistula vs arteriovenous graft vascular access strategyMatthew P Goldman, Dipal M Patel, Kevin Z Chang, et al.
Cell Chemical Biology|October 21, 2020
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.
Pageof 86